Soluble programmed cell death-ligand 1 as a new potential biomarker associated with acute coronary syndrome

BACKGROUND: Soluble programmed cell death-ligand 1 (sPD-L1) has been well documented to activate immunosuppression and is considered an essential predictor of negative clinical outcomes for several malignances and inflammatory conditions. However, the clinical significance of sPD-L1 in the periphera...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuping, Yi, Ling, Wei, Xiqing, Zhang, Jinguo, Wang, Xiaojue, Jiang, Chang, Yan, Zhuohong, Song, Liwei, Yang, Bin, Wei, Panjian, Gao, Xiang, Wang, Jinghui, Zhang, Hongtao, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478490/
https://www.ncbi.nlm.nih.gov/pubmed/36119741
http://dx.doi.org/10.3389/fcvm.2022.971414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478490/
https://www.ncbi.nlm.nih.gov/pubmed/36119741
http://dx.doi.org/10.3389/fcvm.2022.971414

Ejemplares similares